Popular on s4story
- Akiti the Hunter Launches Mission to Deliver One Million Books to One Million Children Worldwide - 107
- Sun Gate Golf Retirement Community Doesn't have a Shuffleboard. It Solves Murder Mysteries - 105
- Dividend Stacker Launches Free Calendar and Alerts for High-Yield ETF Payouts
- Johnnie Mandela Releases THOUGHT in the Age of AI
- Black Dog Venture Partners and VC Fast Pitch to Host "San Francisco Investors and Innovators" Networking Event
- Share Your Story Event: Your Voice, Your Story
- Wilber Chitambo's From Pain to Purpose: A Healing Journey Offers a Powerful Testament to Healing
- New Book Revisits Berny Dohrmann, CEO Space and the People Who Powered The Space
- New Book Asks Caregivers to Look Past Dementia—and See the Person
- DAZN Review 2026: Streaming Price Worth It?
Similar on s4story
- Warrant Activity, AVERSA™ Progress and a Potentially Transformative Fall Take Center Stage: Nutriband Inc. (N A S D A Q: NTRB)
- Infinity Infusion Solutions Named Finalist for D Magazine's D CEO 2026 Excellence in Healthcare Awards
- Building a Diversified Healthcare Platform as Exosome Science, Telehealth, Diagnostics & Strategic Acquisitions Converge: NexTel Medical (OTCID: MAJI)
- International Society of Medical AI Convenes Global Faculty in Florence for ISMAI 2026
- Lawsuit Alleges American Deli Food Caused Severe Illness, Acute Kidney Failure, And Eight-day Hospitalization
- European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
- Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
- Mandeville Pests May Pose Serious Health Risks for Your Family
xBxBio Opens EU, Asia and Latin America Regulatory Leadership Searches
S For Story/10703197
xBxBio seeks three senior vice presidents to guide regional regulatory strategy, governance, and evidence planning for its developing cardiovascular intelligence platform.
IRVINE, Calif. - s4story -- xBxBio is seeking three senior vice presidents to strengthen regulatory strategy and governance for its developing cardiovascular intelligence platform, with one position each for the European Union, Asia, and Latin America.
The searches support preparation for future international development by bringing regional expertise into scientific, engineering, clinical, and quality planning.
xBxBio is developing Connected Cardiovascular Intelligence™ to help clinicians assess patient-specific cardiovascular information across sources and over time when developing recommendations for individual patients. Regional leaders will help connect development priorities with applicable requirements, evidence needs, and quality processes.
Senior Vice President, Regulatory Affairs & Governance — European Union
This leader will guide EU regulatory strategy for applicable medical-device software and clinical AI functions. Responsibilities include intended-use and classification assessments, conformity assessment planning, clinical evidence strategy, and coordination with quality, engineering, clinical, privacy, and legal specialists.
More on S For Story
Senior Vice President, Regulatory Affairs & Governance — Asia
This leader will develop country-specific strategies for selected Asian markets. Responsibilities include helping to prioritize jurisdictions, assessing regulatory pathways and evidence requirements, identifying local expertise, and coordinating submission planning.
Senior Vice President, Regulatory Affairs & Governance — Latin America
This leader will develop country-specific strategies for selected Latin American markets. Responsibilities include assessing product classification and registration pathways, identifying local representation and documentation requirements, and coordinating evidence and submission planning with regional specialists.
Both Asia and Latin America require strategies tailored to individual countries. All three leaders will support the regional application of xBxBio's Regulatory-by-Design Framework, emphasizing traceable decisions, evidence planning, risk management, and accountable human oversight.
Candidate qualifications
Candidates should demonstrate substantial regional experience with medical devices, medical software, or clinical AI; multidisciplinary leadership; and a verifiable record of translating regulatory requirements into practical development and evidence plans.
More on S For Story
How to apply
Email HR@xbxbio.com with a current executive CV or résumé, a concise statement of qualifications, and five verifiable examples of relevant results you personally led or materially contributed to. Describe your contribution, outcomes, and experience with specific jurisdictions and regulatory pathways.
Use "SVP Regulatory Affairs & Governance — EU," "SVP Regulatory Affairs & Governance — Asia," or "SVP Regulatory Affairs & Governance — Latin America" in the subject line. Exclude confidential, proprietary, patient-identifiable, or otherwise restricted information.
About xBxBio
xBxBio is developing a cardiovascular intelligence platform focused on longitudinal clinical context, multimodal information, interoperability, data integrity, and clinician-guided recommendations.
The company remains in pre-commercial research and engineering development. Future clinical deployment and commercialization depend on appropriate verification, validation, clinical evidence, and applicable regulatory requirements and authorizations.
Website: https://www.xbxbio.com
Executive applications: HR@xbxbio.com
The searches support preparation for future international development by bringing regional expertise into scientific, engineering, clinical, and quality planning.
xBxBio is developing Connected Cardiovascular Intelligence™ to help clinicians assess patient-specific cardiovascular information across sources and over time when developing recommendations for individual patients. Regional leaders will help connect development priorities with applicable requirements, evidence needs, and quality processes.
Senior Vice President, Regulatory Affairs & Governance — European Union
This leader will guide EU regulatory strategy for applicable medical-device software and clinical AI functions. Responsibilities include intended-use and classification assessments, conformity assessment planning, clinical evidence strategy, and coordination with quality, engineering, clinical, privacy, and legal specialists.
More on S For Story
- Warrant Activity, AVERSA™ Progress and a Potentially Transformative Fall Take Center Stage: Nutriband Inc. (N A S D A Q: NTRB)
- Put Your Herd on Your Phone: Kiko Nation Makes Livestock Management Simple
- Future Intelligence Think Tank Surpasses 1,000 Members Exploring Human and Artificial Intelligence
- Humphrey Jr. Returns Brings a Beloved Northern California Whale Story to a New Generation
- Gary Bernstein Expands Media Leadership Role With Senior Strategic Advisor Appointment To Blacksun Private Equity
Senior Vice President, Regulatory Affairs & Governance — Asia
This leader will develop country-specific strategies for selected Asian markets. Responsibilities include helping to prioritize jurisdictions, assessing regulatory pathways and evidence requirements, identifying local expertise, and coordinating submission planning.
Senior Vice President, Regulatory Affairs & Governance — Latin America
This leader will develop country-specific strategies for selected Latin American markets. Responsibilities include assessing product classification and registration pathways, identifying local representation and documentation requirements, and coordinating evidence and submission planning with regional specialists.
Both Asia and Latin America require strategies tailored to individual countries. All three leaders will support the regional application of xBxBio's Regulatory-by-Design Framework, emphasizing traceable decisions, evidence planning, risk management, and accountable human oversight.
Candidate qualifications
Candidates should demonstrate substantial regional experience with medical devices, medical software, or clinical AI; multidisciplinary leadership; and a verifiable record of translating regulatory requirements into practical development and evidence plans.
More on S For Story
- A. Q. Adams Completes New Short Story
- Headline: House of Nova Paints Every Face in Gold at New York Fashion Week
- Can Government Operate Better Through Innovation?
- Michael H. Kaplan Advocates for Seriously Injured Colorado Workers Who Need In-Home Care
- Governor Laura Kelly Proclaims September 26 University Press of Kansas Day
How to apply
Email HR@xbxbio.com with a current executive CV or résumé, a concise statement of qualifications, and five verifiable examples of relevant results you personally led or materially contributed to. Describe your contribution, outcomes, and experience with specific jurisdictions and regulatory pathways.
Use "SVP Regulatory Affairs & Governance — EU," "SVP Regulatory Affairs & Governance — Asia," or "SVP Regulatory Affairs & Governance — Latin America" in the subject line. Exclude confidential, proprietary, patient-identifiable, or otherwise restricted information.
About xBxBio
xBxBio is developing a cardiovascular intelligence platform focused on longitudinal clinical context, multimodal information, interoperability, data integrity, and clinician-guided recommendations.
The company remains in pre-commercial research and engineering development. Future clinical deployment and commercialization depend on appropriate verification, validation, clinical evidence, and applicable regulatory requirements and authorizations.
Website: https://www.xbxbio.com
Executive applications: HR@xbxbio.com
Source: xBxBio
0 Comments
Latest on S For Story
- Lee Gunn IV Shares Lessons From 40 Years in the Courtroom on PodNumbra Podcast
- [New Book] "Historic Maps of Philadelphia" Available Now!
- Michael H. Kaplan Recognized for 17 Years on PHPA Workers' Compensation Panel and Advocacy for Professional Athletes
- International Society of Medical AI Convenes Global Faculty in Florence for ISMAI 2026
- Boston Industrial Solutions Introduces Personalized Printing Training
- Century Fasteners de Mexico Exhibiting at the 2026 Automotive & Aerospace Nearshoring Summit
- Eagle Book Publishing Expands Publishing Support for UK Authors
- Retell AI White Label Platform for Agencies Launched by VoiceAIWrapper, With Branded Client Portals and No Per-Minute Markup
- New Book Announcement - Nixon's War with Students: Campus Unrest in the Vietnam Era
- New Book Announcement - Shokhí: A Kanza Relative, a Monument, and Rematriation
- FOCUS Names Mark Phillips Senior Vice President of Business Development
- Notaron Expands Online Notarization Access Following Wisconsin Approval
- Michelle Carey Releases Maryland Political Thriller, The Crofton Triangle
- Terry E. Gunn Releases New Children's Picture Book A Silly DOG Named Klaus
- She Ran Hospitals Before Learning What Leadership Cost Her. Her New Book Helps Other Women Avoid It
- Wings Air Helicopters Selected to Support VIP Transportation for Resorts World in New York
- Scoop Social Co. Brings Its Signature Mobile Dessert Experience to Houston This October
- The Social Capital Revolution Comes to Phoenix!
- Lawsuit Alleges American Deli Food Caused Severe Illness, Acute Kidney Failure, And Eight-day Hospitalization
- FBI/DoW plot uncovered to hurt Trump/Vance through encouraged "widespread" cybersecurity breaches and racketeering theft of $80m in USDA payments